PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

Overview of attention for article published in Journal of Translational Medicine, June 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 12,271 followers.

RT @ACortelliniMD: Could there be some downside from getting more and more confident with singleagent IO🤔 https://t.co/JHmbrqG26a That's co…

RT @Al3ssandroRusso: Just published an interesting analysis on PD-1/PD-L1 checkpoint inhibitors during late stages of life. Very few days o…

RT @ACortelliniMD: Could there be some downside from getting more and more confident with singleagent IO🤔 https://t.co/JHmbrqG26a That's co…

RT @Al3ssandroRusso: Just published an interesting analysis on PD-1/PD-L1 checkpoint inhibitors during late stages of life. Very few days o…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.